Cite
MLA Citation
John M Wrangle et al.. “ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial.” Lancet oncology, vol. 19, no. 5, 2018, pp. 694–704. http://access.bl.uk/ark:/81055/vdc_100060491107.0x000014